These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 25466298)
1. Role of ADHD symptoms as a contributing factor to obesity in patients with MC4R mutations. Porfirio MC; Giovinazzo S; Cortese S; Giana G; Lo-Castro A; Mouren MC; Curatolo P; Purper-Ouakil D Med Hypotheses; 2015 Jan; 84(1):4-7. PubMed ID: 25466298 [TBL] [Abstract][Full Text] [Related]
2. Attention deficit hyperactivity disorder in obese melanocortin-4-receptor (MC4R) deficient subjects: a newly described expression of MC4R deficiency. Agranat-Meged A; Ghanadri Y; Eisenberg I; Ben Neriah Z; Kieselstein-Gross E; Mitrani-Rosenbaum S Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1547-53. PubMed ID: 18777518 [TBL] [Abstract][Full Text] [Related]
3. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review. Valette M; Bellisle F; Carette C; Poitou C; Dubern B; Paradis G; Hercberg S; Muzard L; Clément K; Czernichow S Int J Obes (Lond); 2013 Aug; 37(8):1027-35. PubMed ID: 23147118 [TBL] [Abstract][Full Text] [Related]
4. Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder. Albayrak O; Albrecht B; Scherag S; Barth N; Hinney A; Hebebrand J Eur J Pharmacol; 2011 Jun; 660(1):165-70. PubMed ID: 21211528 [TBL] [Abstract][Full Text] [Related]
5. A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity. Valli-Jaakola K; Palvimo JJ; Lipsanen-Nyman M; Salomaa V; Peltonen L; Kontula K; Schalin-Jäntti C Horm Res; 2006; 66(2):61-9. PubMed ID: 16710097 [TBL] [Abstract][Full Text] [Related]
6. Treatment options for children with monogenic forms of obesity. Hainerová IA; Lebl J World Rev Nutr Diet; 2013; 106():105-12. PubMed ID: 23428688 [TBL] [Abstract][Full Text] [Related]
7. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis. Hainerová I; Larsen LH; Holst B; Finková M; Hainer V; Lebl J; Hansen T; Pedersen O J Clin Endocrinol Metab; 2007 Sep; 92(9):3689-96. PubMed ID: 17579204 [TBL] [Abstract][Full Text] [Related]
9. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population. Ochoa MC; Azcona C; Biebermann H; Brumm H; Razquin C; Wermter AK; Martínez JA; Hebebrand J; Hinney A; Moreno-Aliaga MJ; Marti A; Patiño A; Chueca M; Oyarzabal M; Pelach R; Clin Endocrinol (Oxf); 2007 May; 66(5):652-8. PubMed ID: 17492953 [TBL] [Abstract][Full Text] [Related]
10. [Obesity caused by melanocortin-4 receptor mutations]. van den Berg L; Glorie-Docter M; van den Akker E; Delemarre-van de Waal HA Ned Tijdschr Geneeskd; 2012; 156(32):A4548. PubMed ID: 22871247 [TBL] [Abstract][Full Text] [Related]
11. The Melanocortin System behind the Dysfunctional Eating Behaviors. Micioni Di Bonaventura E; Botticelli L; Tomassoni D; Tayebati SK; Micioni Di Bonaventura MV; Cifani C Nutrients; 2020 Nov; 12(11):. PubMed ID: 33202557 [TBL] [Abstract][Full Text] [Related]
12. Obesity and ADHD: clinical and neurobiological implications. Cortese S; Vincenzi B Curr Top Behav Neurosci; 2012; 9():199-218. PubMed ID: 21845534 [TBL] [Abstract][Full Text] [Related]
13. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666 [TBL] [Abstract][Full Text] [Related]
14. Homozygous null mutation of the melanocortin-4 receptor and severe early-onset obesity. Dubern B; Bisbis S; Talbaoui H; Le Beyec J; Tounian P; Lacorte JM; Clément K J Pediatr; 2007 Jun; 150(6):613-7, 617.e1. PubMed ID: 17517245 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Tao YX Mol Cell Endocrinol; 2005 Jul; 239(1-2):1-14. PubMed ID: 15975705 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. Larsen LH; Echwald SM; Sørensen TI; Andersen T; Wulff BS; Pedersen O J Clin Endocrinol Metab; 2005 Jan; 90(1):219-24. PubMed ID: 15486053 [TBL] [Abstract][Full Text] [Related]
17. [The relationship between attention deficit hyperactivity disorders (ADHD) and obesity]. Raziel A; Sakran N; Goitein D Harefuah; 2014 Sep; 153(9):541-5, 557. PubMed ID: 25417492 [TBL] [Abstract][Full Text] [Related]
18. Does dopaminergic reward system contribute to explaining comorbidity obesity and ADHD? Liu LL; Li BM; Yang J; Wang YW Med Hypotheses; 2008; 70(6):1118-20. PubMed ID: 18158220 [TBL] [Abstract][Full Text] [Related]
19. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Reinehr T; Hebebrand J; Friedel S; Toschke AM; Brumm H; Biebermann H; Hinney A Obesity (Silver Spring); 2009 Feb; 17(2):382-9. PubMed ID: 18997677 [TBL] [Abstract][Full Text] [Related]
20. Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis. Hinney A; Volckmar AL; Knoll N Prog Mol Biol Transl Sci; 2013; 114():147-91. PubMed ID: 23317785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]